Rabelense-L Capsule SR
Manufacturer
Medilance Healthcare
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Key Information
Short Description
Rabelense-L Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome.
Dosage Form
Capsule SR
Introduction
Rabelense-L Capsule SR is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect or be affected by this medicine.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Rabelense-L Capsule SR is to be taken empty stomach.
Safety Information
Side Effects
The most common side effects are nausea, stomach pain, diarrhea, flatulence, constipation, headache, weakness, and flu-like symptoms.
Alcohol Warning
It is unsafe to consume alcohol with Rabelense-L Capsule SR.
Breastfeeding Warning
Information regarding the use of Rabelense-L Capsule SR during breastfeeding is not available. Please consult your doctor.
Pregnancy Warning
Rabelense-L Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Rabelense-L Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole.
Quick Tips
It is a well-tolerated medicine and provides relief for a long time. Take it one hour before the meal preferably in the morning. Inform your doctor if you get watery diarrhea, fever, or stomach pain that does not go away. Do not consume alcohol while taking Rabelense-L Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Rabelense-L Capsule SR for longer than prescribed.
Related Medicines
Colosafe-L Capsule SR
Rabemac LS Capsule
Acera-L Capsule SR
Veloz L Capsule
Robeen-L Capsule SR
Ansuper-Plus Capsule SR
Rabonik Plus Capsule SR
Rablet L Capsules
Razo-L Capsule
Rabegroo-L Capsule SR
Frequently asked questions
What is the recommended timing for taking Rabelense-L Capsule SR?
Take Rabelense-L Capsule SR exactly as directed by your doctor. It is best to take one capsule daily on an empty stomach.
What are potential contraindications to using Rabelense-L Capsule SR?
Avoid use of Rabelense-L Capsule SR in patients with known allergy to any of the components or excipients of this medicine.
Can Rabelense-L Capsule SR cause dizziness?
Yes, some individuals may experience dizziness (feeling faint, weak, unsteady, or lightheaded) while using Rabelense-L Capsule SR. If you experience dizziness, rest for a while and resume when feeling better.
Does the use of Rabelense-L Capsule SR elevate fracture risk?
Several studies in adults suggest that treatment with Rabelense-L Capsule SR may be associated with an increased risk of osteoporosis-related fractures of the hip, wrist, or spine. The risk was elevated in patients receiving high doses, which include multiple daily doses and long-term therapy (one year or longer).
Can I drive while taking Rabelense-L Capsule SR?
Taking Rabelense-L Capsule SR may cause drowsiness, dizziness, or affect vision. Do not drive or operate machinery until you understand its effects on your body.
What are the storage and disposal instructions for Rabelense-L Capsule SR?
Store Rabelense-L Capsule SR in its original packaging, tightly sealed. Follow the instructions on the label or package for proper storage. Do not consume the unused medicine. Keep it out of reach of pets, children, and others.
